Type 2 Diabetes — Trials, FDA Actions & Pivotal Research
91 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Type 2 Diabetes.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Type 2 Diabetes trials
Recruiting trials by city
Cities where Type 2 Diabetes trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedType 2 Diabetes: Dynamically Tailored Intervention Reduces HbA1c· May 13, 2026
- Results postedType 2 Diabetes: DASH4D Diet Lowers Blood Pressure and Glucose· May 13, 2026
- Results postedSemaglutide + Lower Insulin Glargine Reduces HbA1c, Weight in T2D· May 11, 2026· drug: Semaglutide
- Results postedType 2 Diabetes: Basic Needs Navigation Shows No Significant HbA1c Change· May 4, 2026
- Results postedAsthma: P-STEP Mobile App Usability Scores Increase Over 12 Weeks· May 1, 2026
- Results postedType 2 Diabetes Pilot Trial: HbA1c Increased in Both Intervention Groups· Apr 28, 2026
- Results postedSemaglutide 7.2 mg Shows Superior Weight Loss in Obesity, Type 2 Diabetes· Apr 27, 2026· drug: Semaglutide
- Results postedType 2 Diabetes: Results Posted for Hispanic/Latinx CKD Screening & Treatment· Apr 24, 2026
- Results postedOrforglipron Phase 3 Trial Shows Significant HbA1c Reduction in Type 2 Diabetes· Apr 22, 2026· drug: Orforglipron
- Results postedVirtual Cardiometabolic Program Reduces BP, Weight in African Immigrants· Apr 22, 2026
- Results postedType 2 Diabetes: Inpatient Insulin Calculator Reduces Hyperglycemia· Apr 15, 2026
- Results postedTrial results posted: NCT05144984· Apr 9, 2026· drug: Semaglutide
- Results postedObesity: High Intensity Weight Loss Reduces Body Weight by 10.73 kg· Apr 3, 2026
- Results postedDepression: Mindfulness Intervention Trial Posts Feasibility Results· Apr 2, 2026
- Results postedPower-Up Program for Type 2 Diabetes Shows Greater Mean Weight Loss· Mar 30, 2026
- Results postedType 2 Diabetes: AI Closed Loop System Achieves 97.25% Glucose Control· Mar 27, 2026
- Results postedType 2 Diabetes: Less Sitting Time Improves Daily Glucose Profile· Mar 24, 2026
- Results postedType 2 Diabetes: DECIDE Program Trial Results Posted for Task Analysis Study· Mar 20, 2026
- Primary completionOrforglipron Phase 3 Trial for Type 2 Diabetes and Obesity Completes Primary…· Mar 16, 2026· drug: Orforglipron
- Results postedType 2 Diabetes Education Study Posts Initial HbA1c Results· Mar 6, 2026
- Primary completionCagriSema Phase 3 Trial for Type 2 Diabetes Completes Primary Data Collection· Mar 4, 2026· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Results postedType 2 Diabetes: Nutrition-Focused CGM Initiation Improves Time in Range· Mar 4, 2026
- Results postedType 2 Diabetes: CGM-Based Insulin Titration Improves Glycemic Control· Mar 4, 2026
- Results postedType 2 Diabetes: Home DM-BAT Shows Slightly Lower HbA1c in Seniors· Feb 24, 2026
- Results postedType 2 Diabetes: STEPS Mobile Program Shows No Significant Weight Loss Benefit· Feb 23, 2026
- Results postedType 2 Diabetes: IAREP Shows Improved Cognitive Function in High-Risk Patients· Feb 19, 2026
- Primary completionDapagliflozin Comparator Trial for Type 2 Diabetes Reaches Primary Completion· Feb 18, 2026· drug: Dapagliflozin
- Results postedDapagliflozin Vascular Health Trial for Type 2 Diabetes Terminated Early· Feb 11, 2026· drug: Dapagliflozin
- Results postedLiraglutide Shows Longer Time to HbA1c >=7% in Type 2 Diabetes GRADE Study· Feb 10, 2026· drug: Liraglutide
- Primary completionDulaglutide: Phase 3 Trial for Type 2 Diabetes Mellitus Completes Primary· Feb 3, 2026· drug: Dulaglutide
- Results postedType 2 Diabetes: FoodSteps Mobile Intervention Achieves High Recruitment and…· Jan 28, 2026
- Results postedType 2 Diabetes: M2-PRIME Consultation Trial Posts Blood Sugar Data· Jan 23, 2026
- Results postedType 2 Diabetes: DyaMX Endoscopic Intervention Shows HbA1c Reduction· Jan 22, 2026
- Results postedSemaglutide in Type 2 Diabetes, CKD: No Significant Impact on Kidney Oxygenation· Jan 14, 2026· drug: Semaglutide
2025
- Primary completionInsulin Degludec Phase 3 Study for Type 2 Diabetes Reaches Primary Completion· Dec 31, 2025· drug: Liraglutide
- Results postedType 2 Diabetes: Community Health Workers Reduce A1c by 0.35%· Dec 22, 2025
- Results postedType 2 Diabetes: Endogenex Device Shows HbA1c Reduction, No SAEs· Dec 22, 2025
- Results postedType 2 Diabetes: Trial Results Posted for Personalized Care Interventions· Dec 17, 2025
- Primary completionSurvodutide Phase 3 Trial for Obesity and Type 2 Diabetes Completes Primary…· Dec 12, 2025· drug: Survodutide
- Results postedType 2 Diabetes: CGM Use Post-Discharge Shows Improved Time in Range· Dec 9, 2025
- Results postedType 2 Diabetes: Mindfulness-Enhanced Diet Education Trial Results Posted· Dec 8, 2025
- Results postedType 2 Diabetes: GA-Guided Therapy Shows Improved HbA1c <6.5% Achievement· Dec 4, 2025
- Results postedEmpagliflozin: MACE Incidence Data Posted for Diabetes Regimen Comparison· Nov 21, 2025· drug: Empagliflozin
- Primary completionCagriSema Phase 3 Trial for Type 2 Diabetes Reaches Primary Completion· Nov 19, 2025· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Primary completionLiraglutide/Insulin Degludec Phase 3 Trial Primary Completion Expected October…· Oct 31, 2025· drug: Liraglutide
- Results postedTirzepatide Monotherapy Shows Significant HbA1c Reduction in Type 2 Diabetes· Oct 21, 2025· drug: Tirzepatide
- Results postedDapagliflozin Combination Shows Lower Mean Weight in Obesity, Pre-Diabetes, T2D· Oct 15, 2025· drug: Dapagliflozin
- Results postedContinuous Glucose Monitoring Improves Hospitalized Type 2 Diabetes Time in…· Oct 15, 2025
- Results postedHeart Failure: 807 Rehospitalizations Reported in Transition Study· Oct 8, 2025
- Results postedType 2 Diabetes: TARDIS Study Reports Mean Diabetes Distress, HbA1c· Oct 8, 2025
- Results postedType 2 Diabetes: Results Posted for Overtreatment in Elderly· Oct 7, 2025
- Results postedType 1 Diabetes: Online Stress Interventions Yield Similar A1C Changes· Oct 2, 2025
- Primary completionCagriSema Phase 3 Trial for Type 2 Diabetes Reaches Primary Completion· Oct 1, 2025· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Results postedTirzepatide Significantly Lowers HbA1c in Pediatric Type 2 Diabetes· Sep 26, 2025· drug: Tirzepatide
- Primary completionDapagliflozin Phase 3 Trial vs Orforglipron in Type 2 Diabetes Completes· Sep 26, 2025· drug: Dapagliflozin
- Results postedOral Semaglutide Reduces Major Adverse CV Events in Type 2 Diabetes· Sep 22, 2025· drug: Semaglutide
- Results postedType 2 Diabetes Education Trial Shows Varied Impact on Distress, QoL· Sep 22, 2025
- Primary completionMazdutide Phase 3 Trial for Type 2 Diabetes and Obesity Reaches Primary…· Sep 17, 2025· drug: Mazdutide
- Primary completionOrforglipron Phase 3 Trial for Type 2 Diabetes Reaches Primary Completion· Sep 15, 2025· drug: Orforglipron
- Results postedType 2 Diabetes: Fit 24 Intervention Shows Higher Sleep Minutes in Adolescents· Sep 15, 2025
- Results postedType 2 Diabetes: Artificial Sweeteners Show Similar HbA1c to Water· Sep 11, 2025
- Results postedSemaglutide Shows Increased EPC Gene Expression in Type 2 Diabetes· Sep 9, 2025· drug: Semaglutide
- Primary completionCagriSema Phase 3 Trial for Type 2 Diabetes Reaches Completion· Sep 9, 2025· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Primary completionSemaglutide Trial for Type 2 Diabetes Completes Primary Phase· Aug 30, 2025· drug: Semaglutide
- Results postedEmpagliflozin/Linagliptin Reduces HbA1c in Korean Type 2 Diabetes· Aug 27, 2025· drug: Empagliflozin
- Results postedInsulin Icodec Shows Greater HbA1c Reduction in Type 2 Diabetes Trial· Aug 26, 2025· drug: Liraglutide
- Primary completionOrforglipron Phase 3 Trial for Type 2 Diabetes Reaches Primary Completion· Aug 22, 2025· drug: Orforglipron
- Results postedType 2 Diabetes: Exercise Training Adipose Tissue Characteristics Posted· Aug 14, 2025
- Primary completionOrforglipron Phase 3 Trial for Obesity and Type 2 Diabetes Completes Primary…· Aug 8, 2025· drug: Orforglipron
- Results postedCV-Homes Intervention Shows Acceptability and Engagement in Homeless Adults· Aug 8, 2025
- Results postedDulaglutide: Tirzepatide Switch Shows Superior HbA1c and Weight Reduction in…· Aug 3, 2025· drug: Dulaglutide
- Results postedType 2 Diabetes Pilot Trial: Nutrition-Supported Education Shows No Benefit· Jul 29, 2025
- Results postedType 2 Diabetes: Terminated Trial Shows Higher A1c, SBP in Intervention· Jul 18, 2025
- Results postedType 1 Diabetes: Closed-Loop System Shows 1.4% Hypoglycemia, 79% Time in Range· Jul 17, 2025
- Results postedType 2 Diabetes: Patient Portal Intervention Trial Results Posted· Jul 10, 2025
- Results postedSemaglutide Improves Walking Distance, Quality of Life in PAD with T2D· Jul 8, 2025· drug: Semaglutide
- Results postedObesity: Family Diabetes Prevention Program Pilot Study Attendance Results…· Jul 8, 2025
- Results postedType 2 Diabetes: Medicaid Health Home Linked to Fewer Hospitalizations· Jul 4, 2025
- Results postedType 2 Diabetes: Dulce Digital-Me mHealth Trial Results Posted· Jun 25, 2025
- Results postedHEARTS Implementation in Guatemala Shows Feasibility, 41% Glycemic Control· Jun 19, 2025
- Results postedObesity: Exercise Alters Gut Microbiome and Cardiometabolic Markers· Jun 13, 2025
- Primary completionDulaglutide: Phase 3 Trial vs. Tirzepatide in Type 2 Diabetes Completes· Jun 12, 2025· drug: Dulaglutide
- Results postedType 2 Diabetes: Fresh Food Farmacy Trial Shows No Significant Glycemic Impact· Jun 12, 2025
- Results postedEversense CGM System Shows Long-term Safety and Effectiveness in Diabetes· Jun 12, 2025
- Results postedType 2 Diabetes: Exercise Approaches Show Similar HbA1c and Activity Levels· Jun 12, 2025
- Results postedObesity Trial PREMIER: Genotype Group Shows Lower Glucose Levels· Jun 8, 2025
- Results postedType 2 Diabetes Neuromodulation Trial Terminated After Low Enrollment· Jun 6, 2025
- Primary completionOrforglipron Phase 3 Long-Term Safety Study in Type 2 Diabetes Completes· Jun 5, 2025· drug: Orforglipron
- Results postedLiraglutide Alias Insulin Degludec Requires Higher Weekly Dose Than Efsitora…· Jun 3, 2025· drug: Liraglutide
- Results postedType 2 Diabetes: Fruit-Rich Diet Shows Improved Glycemic Control and Remission· May 23, 2025
- Results postedType 2 Diabetes: Dapagliflozin/Metformin Combo Improves Glycemic Control· May 22, 2025